ABOUT US

KnoWhereBio advances in the development of first-in-class drugs through redox science to improve the human life span and the quality of life in epigenetics.

KnoWhereBio believes that the science and technology of redox biochemistry & post-translational modification lead to the development of first-in-class drugs against diabetes-related illnesses and cancers which makes KnoWhereBio the leader as a new global innovation company in the treatment of untreatable diseases.

While most research on the regulation of signal transduction mechanisms focuses on phosphorylation and the research on the regulation of signal transduction involving oxidative and nitrosative stresses being unique, Knowherebio has distinctive technology for reinterpreting cellular signaling regulation and redox regulation and in epigenetics’ target proteins.

 

NEWS

 

CONTACT US

Kn (13449) 416-418, 42 Changeop-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do

T. +82-2-2038-6735

 
 

INQUIRY

 

© KnoWhereBio Co., Ltd.

  • Facebook
  • Twitter
  • YouTube
  • 회색 링크드 인 아이콘